JamersonBDDukesGEBrouwerKLRDonnKHMessenheinmerJAPowellJR. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy1994;14:47–52.
2.
BoucherBAFelerCADeanJCMichieDDTiptonBKSmithKRJrThe safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients. Pharmacotherapy1996;16:638–45.
3.
1998 Drug topics red book. Montvale, NJ: Medical Economics Co., 1998:222.
4.
SpenglerRFArrowsmithJBKilarskiDJBuchananCVon BehrenLGrahamDR. Severe soft-tissue injury following intravenous infusion of phenytoin: Patient and drug administration risk factors. Arch Intern Med1988;148:1329–33.
5.
EarnestMPMarxJADruryLR. Complications of intravenous phenytoin for acute treatment of seizures. JAMA1983;249:762–5.
6.
HannaDR. Purple glove syndrome: A complication of intravenous phenytoin. J Neurosci Nurs1992;24:340–5.
7.
BatesDWCullenDJLairdNPetersenLASmallSDServiDIncidence of adverse drug events and potential adverse drug events. JAMA1995;274:29–34.
8.
American College of Surgeons.Data sources and coordination. In: Patient safety manual. Rockville, MD: Bader & Associates, Inc., 1985:111–42.
9.
KeithMRBellanger-McCleeryRAFuchsJEJr.Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm1989;46:1809–12.
10.
HartwigSCDengerSDSchneiderPJ. Severity index, incident report— Based medication error—reporting program. Am J Hosp Pharm1991;48: 2611–6.
11.
CullenDJBatesDWSmallSDCooperJBNemeskalARLeapeLL. The incident reporting system does not detect adverse drug events: A problem for quality improvement. J Qual Improv1995;21:541–52.
12.
WhitmanM. The push is on: Delivering medications safely by I.V. bolus. Nursing951995;(August):52–5.
13.
McGovernK. Ten golden rules for administering drugs safely. Nursing921992;(March):49–56.
14.
O'BrienTJCascinoGDSoELHannaDR. Incidence and clinical consequences of the purple-glove syndrome in patients receiving intravenous phenytoin (abstract). Epilepsia1997;38(suppl 8):90–1.
15.
WelshCHPedotRAndersonRJ. Use of morning report to enhance adverse event detection. J Gen Intern Med1996;11:454–60.
